Saurin J Shah, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 845 S Town And River Drive, Ft Myers, FL 33919 Phone: 239-454-2742 Fax: 239-466-2742 |
News Archive
While coronary artery bypass surgery has long been the standard treatment for patients with the most extensive forms of coronary artery disease, the results of a recent study by an international team of researchers suggests that advances in technology appear to be narrowing the "benefit gap" between the two approaches. The results of the study appear in the March 17, 2011 issue of the New England Journal of Medicine.
Even as some states didn't meet the target set by the Department of Health and Human Services for submitting their "benchmark" plans regarding the health law's essential health benefits, others offered specifics about what would be covered and what plans would be their choice.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and which has embarked in the field of companion diagnostics with a view to progressing in the area of personalized medicine, today announced the signature of an investment agreement with Biocartis.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired the assets of PRN Medical Management, LLC, a medical transcription company serving medical clinics for over 18 years, primarily in Maryland, Washington DC, and Virginia. With the acquisition of PRN, iMedX expands its base in the Washington DC metro area and beyond. PRN's employees in India will be absorbed by iMedX's subsidiary Worldtech.
Pharmacyclics, Inc. today announced that it has increased the number of shares to be sold in the registered direct offering previously announced on June 15, 2010 by approximately 1.9 million shares, for a total offering of approximately 8 million shares. The increase in the number of shares was due to additional demand from institutional investors who were previously participating in the registered direct offering.
› Verified 2 days ago